Intraperitoneal versus Intravenous Cisplatin in Combination with Intravenous Cyclophosphamide and Epidoxorubicin in Optimally Cytoreduced Advanced Epithelial Ovarian Cancer: A Randomized Trial of the Gruppo Oncologico Nord-Ovest

This publication has 17 references indexed in Scilit:

• Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study.
  Journal of Clinical Oncology, 1998
• Intraperitoneal Carboplatin with or without Interferon-α in Advanced Ovarian Cancer Patients with Minimal Residual Disease at Second Look: A Prospective Randomized Trial of 111 Patients
  Gynecologic Oncology, 1997
• Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
  New England Journal of Medicine, 1996
• Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.
  Journal of Clinical Oncology, 1996
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Intraperitoneal chemotherapy in the management of ovarian cancer
  Cancer, 1993
• Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.
  Journal of Clinical Oncology, 1992
• A review: Intraperitoneal cisplatin in the management of patients with ovarian cancer
  Gynecologic Oncology, 1990
• Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy.
  Journal of Clinical Oncology, 1987
• Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.
  Journal of Clinical Oncology, 1987